PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1844027
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1844027
Wearable diagnostic patches are revolutionizing non-invasive health monitoring, enabling real-time detection of biomarkers for personalized care
Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart rate, through non-invasive contact with sweat or skin. Equipped with wireless communication capabilities, these devices are designed for comfort, long-term use, and integration into remote health monitoring systems.
This report provides an in-depth analysis of the emerging field of second skin diagnostics, focusing on microfluidic and bioelectronic patches used for disease diagnosis. It examines the technological landscape, market readiness, stakeholder activities, and innovation patterns in these segments. The report also offers a comprehensive analysis of the global contract development and manufacturing organization (CDMO) landscape supporting second skin diagnostics development on sensors, adhesives, microfluidics, or battery components. It also identifies the key growth opportunities in second skin diagnostics, focusing on emerging technologies, integration potential, and market enablers that can drive second skin diagnostics from an adjunct tool to standalone diagnostic solutions.
Our latest report explores how second skin diagnostics are transforming the healthcare landscape. By combining microfluidics, flexible electronics, and biosensors, these innovative solutions offer a non-invasive alternative to traditional diagnostic modalities.
The report examines how this technology is shifting diagnostics from the lab to the skin - improving accessibility, speeding up results, and supporting more personalized care.
Discover how second skin diagnostics are paving the way for decentralized, patient-friendly healthcare.